LGALS9 and neoplasm: During activation of anti-tumor-specific responses, exogenous galectin-9 modulates antigen presentation, promoting the differentiation of plasmacytoid dendritic-like cells [217], dendritic cell maturation, and a Th1 polarizing microenvironment [111,228].